Shares of Biogen Inc. BIIB, +1.16% rose 1.4% in premraket trading Wednesday, after the biotechnology company reported second-quarter profit that rose well above expectations, and raised the full-year outlook.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,